Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00954018 · ClinicalTrials.gov registry record
Microbial Community Composition and Metabolism in Cystic Fibrosis
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 100
- Enrollment target
NCT00954018 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 100 participants.
The verdict
NCT00954018 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Scientist have begun to realize that many types of bacteria often live together as a complex community, and the investigators wish to apply that idea to the bacteria in the respiratory system of people with Cystic Fibrosis (CF). It is possible that the survival of the many millions of bacteria in the CF lung depends on the production of special chemicals that might be made only by very few types of bacteria. If that is true, medicines that interfere with those chemicals could treat the lung infections that cause trouble for nearly all people with CF. The investigators wish to study the production of several potentially critical chemicals by the respiratory bacteria and to examine the effect of those chemicals on the makeup of the entire community of bacteria. To detect all the bacteria in that community, the investigators will use new methods that use bacterial genetic information and can detect hundreds of different types of bacteria in respiratory samples of individual CF patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-08 |
| Est. Completion | 2017-11-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00954018
The ClinicalTrials.gov registry entry for NCT00954018 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00954018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00954018 about?
NCT00954018 is a clinical study titled "Microbial Community Composition and Metabolism in Cystic Fibrosis". Scientist have begun to realize that many types of bacteria often live together as a complex community, and the investigators wish to apply that idea to the bacteria in the respiratory system of people with Cystic Fibrosis (CF). It is possible that the survival of the many millions of bacteria in th...
What is the current status of trial NCT00954018?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-08. Estimated completion is 2017-11-10.
Who is sponsoring clinical trial NCT00954018?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.